Skip to content
medxy logo

Medxy AI

  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
Debunking Weight Loss Myths: Avoid These Pitfalls for More Effective and Healthy Weight Loss
Posted inDiabetes & Endocrinology news Specialties

Debunking Weight Loss Myths: Avoid These Pitfalls for More Effective and Healthy Weight Loss

Posted by MedXY By MedXY 08/17/2025
This article explores common weight loss misconceptions, offering scientific insights and strategies for safe and sustainable fat loss.
Read More
Debunking 7 Common Weight Loss Myths: What You Need to Know for Healthy Fat Loss
Posted inDiabetes & Endocrinology news Specialties

Debunking 7 Common Weight Loss Myths: What You Need to Know for Healthy Fat Loss

Posted by MedXY By MedXY 08/17/2025
Explore seven prevalent misconceptions about weight loss—from ignoring obesity as a disease to the dangers of rapid slimming—founded on medical evidence and expert advice to guide safe and effective weight management.
Read More
Mastering the Art of Running: Scientific Guide to Safe and Effective Running
Posted inFamily Medicine & Nutrition news Specialties

Mastering the Art of Running: Scientific Guide to Safe and Effective Running

Posted by MedXY By MedXY 08/17/2025
Discover how to prepare, run, and recover like a pro with scientifically backed tips to enhance your running experience and avoid injuries.
Read More
The Rise of Healthy Running: A Scientific Approach to Fitness
Posted inFamily Medicine & Nutrition news Specialties

The Rise of Healthy Running: A Scientific Approach to Fitness

Posted by MedXY By MedXY 08/17/2025
Healthy running emphasizes sustainable practices for improved health without the competition. Learn effective strategies, common misconceptions, and expert recommendations for a balanced approach to fitness.
Read More
Valve Underexpansion in ACURATE neo2 TAVR: Implications for Clinical Outcomes and Future Directions
Posted inCardiology Clinical Updates news Specialties

Valve Underexpansion in ACURATE neo2 TAVR: Implications for Clinical Outcomes and Future Directions

Posted by MedXY By MedXY 08/17/2025
Underexpansion of the ACURATE neo2 valve during TAVR is linked to increased risk of death, stroke, and rehospitalization at one year, suggesting that achieving optimal valve expansion may improve patient outcomes.
Read More
Tirzepatide’s Role in Obesity-Related HFpEF: Influence of BMI, Central Adiposity, and Weight Loss from the SUMMIT Trial
Posted inCardiology Diabetes & Endocrinology news Specialties

Tirzepatide’s Role in Obesity-Related HFpEF: Influence of BMI, Central Adiposity, and Weight Loss from the SUMMIT Trial

Posted by MedXY By MedXY 08/17/2025
Tirzepatide reduces heart failure risk in obese HFpEF patients regardless of BMI or central adiposity, with greater benefits on exercise capacity and symptom scores associated with higher BMI and weight loss.
Read More
Long-Term Outcomes of Vagus Nerve Stimulation Paired With Upper Extremity Rehabilitation After Stroke
Posted inClinical Updates Neurology news Specialties

Long-Term Outcomes of Vagus Nerve Stimulation Paired With Upper Extremity Rehabilitation After Stroke

Posted by MedXY By MedXY 08/17/2025
This study evaluates the lasting benefits of vagus nerve stimulation combined with rehabilitation for stroke patients suffering from upper extremity impairments.
Read More
SUMMIT MAX Trial Validates Super Large Bore HiPoint System for Effective and Safe Aspiration Thrombectomy in Large Vessel Occlusion Stroke
Posted inNeurology news Specialties

SUMMIT MAX Trial Validates Super Large Bore HiPoint System for Effective and Safe Aspiration Thrombectomy in Large Vessel Occlusion Stroke

Posted by MedXY By MedXY 08/17/2025
The SUMMIT MAX randomized trial demonstrates that the super large bore HiPoint reperfusion system is noninferior to the Vecta system in reperfusion success and safety for acute ischemic stroke due to large vessel occlusion.
Read More
Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis
Posted inClinical Updates Neurology news Specialties

Impact of Prior Reperfusion Strategies on Early versus Late Direct Oral Anticoagulation in Ischemic Stroke: Insights from the ELAN Trial Subanalysis

Posted by MedXY By MedXY 08/17/2025
A subanalysis of the ELAN trial shows that prior reperfusion therapy does not alter the safety or efficacy outcomes of early versus late initiation of direct oral anticoagulants in ischemic stroke patients with atrial fibrillation.
Read More
Thoracentesis in Acute Heart Failure: Insights from the TAP-IT Randomized Controlled Trial
Posted inCardiology news Specialties

Thoracentesis in Acute Heart Failure: Insights from the TAP-IT Randomized Controlled Trial

Posted by MedXY By MedXY 08/17/2025
The TAP-IT trial found that additional thoracentesis in acute heart failure patients with pleural effusion did not improve days alive out of hospital, mortality, or length of stay compared to standard therapy alone.
Read More
Aficamten: A Breakthrough Oral Therapy for Obstructive Hypertrophic Cardiomyopathy Across Symptom Severity
Posted inCardiology Clinical Updates news Specialties

Aficamten: A Breakthrough Oral Therapy for Obstructive Hypertrophic Cardiomyopathy Across Symptom Severity

Posted by MedXY By MedXY 08/17/2025
Aficamten significantly improves exercise capacity and symptoms in obstructive hypertrophic cardiomyopathy (HCM), demonstrating robust efficacy and safety in both mildly and severely symptomatic patients.
Read More
Aficamten in Obstructive Hypertrophic Cardiomyopathy: Durable 48-Week Benefits and Insights on Combination Therapy
Posted inCardiology news Specialties

Aficamten in Obstructive Hypertrophic Cardiomyopathy: Durable 48-Week Benefits and Insights on Combination Therapy

Posted by MedXY By MedXY 08/17/2025
Aficamten shows sustained obstruction relief, symptom improvement, and favorable cardiac remodeling over 48 weeks in obstructive hypertrophic cardiomyopathy, with safe discontinuation of disopyramide possible.
Read More
Unraveling Molecular Links Between Chronic Kidney Disease and Heart Failure via the Plasma Proteome
Posted inCardiology Clinical Updates Nephrology news Specialties

Unraveling Molecular Links Between Chronic Kidney Disease and Heart Failure via the Plasma Proteome

Posted by MedXY By MedXY 08/17/2025
A comprehensive proteomic analysis from the ARIC study identifies plasma proteins linking kidney dysfunction to incident heart failure, highlighting potential biomarkers and therapeutic targets for HF prevention in CKD patients.
Read More
Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction
Posted inCardiology Clinical Updates news Specialties

Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection Fraction

Posted by MedXY By MedXY 08/17/2025
This study explores the Left Atrial Coupling Index as a key predictor in heart failure patients with preserved ejection fraction.
Read More
Antiplatelet vs Anticoagulant Therapy in Embolic Stroke of Undetermined Source: Insights from a Large Multicenter Cohort Study
Posted inClinical Updates Neurology news Specialties

Antiplatelet vs Anticoagulant Therapy in Embolic Stroke of Undetermined Source: Insights from a Large Multicenter Cohort Study

Posted by MedXY By MedXY 08/17/2025
This study found no overall advantage of anticoagulation over antiplatelet therapy in ESUS patients but identified a potential benefit of anticoagulation in those with left ventricular injury.
Read More
Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease
Posted inNeurology news Specialties

Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease

Posted by MedXY By MedXY 08/17/2025
This study explores medication use and its impact on 8-year mortality among patients with Parkinson disease, identifying potential drug repurposing candidates for treatment.
Read More
Noncontrast CT vs CT Perfusion Imaging in Acute Stroke: Comparative Insights from Recent Trials and Systematic Review
Posted inNeurology news Radiology Specialties

Noncontrast CT vs CT Perfusion Imaging in Acute Stroke: Comparative Insights from Recent Trials and Systematic Review

Posted by MedXY By MedXY 08/17/2025
Recent evidence from randomized trials and meta-analyses suggests that noncontrast CT (NCCT) offers comparable outcome prediction to CT perfusion (CTP) for selecting patients with acute ischemic stroke, including basilar artery occlusion, for endovascular therapy (EVT).
Read More
Evaluating Thigh-High Compression Stockings in Preventing Vasovagal Syncope Recurrence: Insights from a Randomized Sham-Controlled Trial
Posted inCardiology Clinical Updates Neurology news Specialties

Evaluating Thigh-High Compression Stockings in Preventing Vasovagal Syncope Recurrence: Insights from a Randomized Sham-Controlled Trial

Posted by MedXY By MedXY 08/17/2025
A randomized sham-controlled trial found that thigh-high elastic compression stockings did not significantly reduce vasovagal syncope recurrence or improve syncope-free survival, though fewer episodes occurred during active stocking use.
Read More
Optimizing Anticoagulant Therapy in Frail Elderly AF Patients: Insights from the COMBINE-AF Substudy
Posted inCardiology Specialties

Optimizing Anticoagulant Therapy in Frail Elderly AF Patients: Insights from the COMBINE-AF Substudy

Posted by MedXY By MedXY 08/17/2025
Switching frail, elderly atrial fibrillation patients from warfarin to standard-dose DOAC reduced stroke, fatal and intracranial bleeding, and death, though gastrointestinal bleeding increased. Major bleeding and net clinical outcome remained similar.
Read More
Vutrisiran’s Impact on Cardiac Function and Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights from HELIOS-B
Posted inCardiology news Specialties

Vutrisiran’s Impact on Cardiac Function and Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights from HELIOS-B

Posted by MedXY By MedXY 08/17/2025
Vutrisiran improves cardiac structure, function, and biomarkers, reducing mortality and cardiovascular events in transthyretin amyloid cardiomyopathy over 30 months.
Read More

Posts pagination

Previous page 1 … 185 186 187 188 189 … 227 Next page
  • Targeting the Integrin αV-YAP-CTGF Axis: A New Frontier in Treating Congestive Hepatopathy and Liver Carcinogenesis
  • From Pressure to Cancer: Unveiling the Integrin αV-YAP-CTGF Axis as a Therapeutic Target in Congestive Hepatopathy
  • Nerandomilast Shows Potential Mortality Benefit in IPF Despite Neutral Composite Secondary Endpoints: Insights from FIBRONEER-IPF Extended Follow-up
  • Beyond the Clot: Novel Proteomic Markers Redefine Venous Thromboembolism Risk
  • The Cardiovascular-Kidney-Metabolic (CKM) Syndrome Revolution: Mapping Medication Eligibility and Multi-Systemic Benefits
Post You Might Like
Posted inCardiology Gastroenterology news
Targeting the Integrin αV-YAP-CTGF Axis: A New Frontier in Treating Congestive Hepatopathy and Liver Carcinogenesis
Posted by MedXY By MedXY 03/28/2026
Posted inCardiology Gastroenterology news
From Pressure to Cancer: Unveiling the Integrin αV-YAP-CTGF Axis as a Therapeutic Target in Congestive Hepatopathy
Posted by MedXY By MedXY 03/28/2026
Posted inInternal Medicine news Respiratory
Nerandomilast Shows Potential Mortality Benefit in IPF Despite Neutral Composite Secondary Endpoints: Insights from FIBRONEER-IPF Extended Follow-up
Posted by MedXY By MedXY 03/28/2026
Posted inCardiology Hematology-Oncology news
Beyond the Clot: Novel Proteomic Markers Redefine Venous Thromboembolism Risk
Posted by MedXY By MedXY 03/28/2026
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality nutrition obesity older adults oncology Pediatrics Physical Activity precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in